Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:289-293

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Comuzzie, A. G.
Right arrow Articles by MacCluer, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Comuzzie, A. G.
Right arrow Articles by MacCluer, J. W.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:289-293.)
© 1996 American Heart Association, Inc.


Articles

Triiodothyronine Exerts a Major Pleiotropic Effect on Reverse Cholesterol Transport Phenotypes

Anthony G. Comuzzie; J. Blangero; Michael C. Mahaney; R. Mark Sharp; John L. VandeBerg; Michael P. Stern; Jean W. MacCluer

From the Department of Genetics, Southwest Foundation for Biomedical Research (A.G.C., J.B., M.C.M., R.M.S., J.L.V., J.W.M.), San Antonio, Tex, and the Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center (M.P.S.), San Antonio, Tex.

Correspondence to Dr Anthony Comuzzie, Department of Genetics, Southwest Foundation for Biomedical Research, PO Box 28147, San Antonio, TX 78228-0147. E-mail agcom@darwin.sfbr.org.

Abstract The thyroid hormone triiodothyronine (T3) is known to be a potent mediator of APOA1 gene expression. With the use of multivariate quantitative genetic analysis, we have assessed the magnitude of shared effects of T3 on plasma concentrations of apolipoprotein AI (apo AI) and three related phenotypes: HDL-C, apo AII, and LpAI (which is a concentration of apo AI that contains HDL particles). Maximum likelihood techniques were used to simultaneously estimate mean effects and variance components in large, extended Mexican American families living in San Antonio, Tex. We found that T3 accounted for 16%, 23%, 21%, and 37% of the additive genetic variance in HDL-C, apo AI, apo AII, and LpAI, respectively, while explaining virtually none of the random environmental variance in these phenotypes. T3 also has a pronounced effect on the pairwise genetic correlations among the four phenotypes: After the pleiotropic effects of T3 concentrations are controlled for, the genetic correlations are reduced by 6% in the case of HDL-C and apo AI and 97% for apo AII and LpAI. Thus, genes that influence T3 have a significant effect on HDL-C, apo AI, apo AII, and LpAI and also on the correlations among these phenotypes.


Key Words: thyroid hormones • HDL-C • apo AI • apo AII • LpAI




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. B. Samollow, G. Perez, C. M. Kammerer, D. Finegold, P. W. Zwartjes, L. M. Havill, A. G. Comuzzie, M. C. Mahaney, H. H. Goring, J. Blangero, et al.
Genetic and Environmental Influences on Thyroid Hormone Variation in Mexican Americans
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3276 - 3284.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. L. Rainwater, L. J. Martin, and A. G. Comuzzie
Genetic Control of Coordinated Changes in HDL and LDL Size Phenotypes
Arterioscler Thromb Vasc Biol, November 1, 2001; 21(11): 1829 - 1833.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. G. Comuzzie, T. Funahashi, G. Sonnenberg, L. J. Martin, H. J. Jacob, A. E. K. Black, D. Maas, M. Takahashi, S. Kihara, S. Tanaka, et al.
The Genetic Basis of Plasma Variation in Adiponectin, a Global Endophenotype for Obesity and the Metabolic Syndrome
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4321 - 4325.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. H. Taylor, Z. F. Stephan, R. E. Steele, and N. C. W. Wong
Beneficial Effects of a Novel Thyromimetic on Lipoprotein Metabolism
Mol. Pharmacol., September 1, 1997; 52(3): 542 - 547.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Blangero, S. Williams-Blangero, M. C. Mahaney, A. G. Comuzzie, J. E. Hixson, P. B. Samollow, R. M. Sharp, M. P. Stern, and J. W. MacCluer
Effects of a Major Gene for Apolipoprotein A-I Concentration Are Thyroid Hormone Dependent in Mexican Americans
Arterioscler Thromb Vasc Biol, September 1, 1996; 16(9): 1177 - 1183.
[Abstract] [Full Text]